Long road ahead for Forest as Lexapro approaches abyss
This article was originally published in Scrip
Executive Summary
Forest Laboratories has posted revenues that come in just above analysts' estimates. Net sales for the third fiscal quarter increased 9% to $1.2 billion from the year-ago period.